000 01248 a2200349 4500
005 20250517051401.0
264 0 _c20160906
008 201609s 0 0 eng d
022 _a1720-8386
024 7 _a10.1007/s40618-015-0385-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRigato, M
245 0 0 _aEffects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case-control study.
_h[electronic resource]
260 _bJournal of endocrinological investigation
_cDec 2015
300 _a1357-63 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCase-Control Studies
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aGlycated Hemoglobin
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadministration & dosage
650 0 4 _aLiraglutide
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTreatment Outcome
700 1 _aAvogaro, A
700 1 _aFadini, G P
773 0 _tJournal of endocrinological investigation
_gvol. 38
_gno. 12
_gp. 1357-63
856 4 0 _uhttps://doi.org/10.1007/s40618-015-0385-5
_zAvailable from publisher's website
999 _c25221418
_d25221418